Carboxymethylcellulose Sodium
"Carboxymethylcellulose Sodium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cellulose derivative which is a beta-(1,4)-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.
| Descriptor ID |
D002266
|
| MeSH Number(s) |
D09.698.365.180.663.329
|
| Concept/Terms |
Carboxymethylcellulose Sodium- Carboxymethylcellulose Sodium
- Sodium, Carboxymethylcellulose
- Carmellose Sodium
- Sodium, Carmellose
- Sodium Carboxymethylcellulose
- Carboxymethylcellulose, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Carboxymethylcellulose Sodium".
Below are MeSH descriptors whose meaning is more specific than "Carboxymethylcellulose Sodium".
This graph shows the total number of publications written about "Carboxymethylcellulose Sodium" by people in this website by year, and whether "Carboxymethylcellulose Sodium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carboxymethylcellulose Sodium" by people in Profiles.
-
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. Neuro Oncol. 2019 07 11; 21(7):923-933.
-
Anticoagulation and antiplatelet therapy in awake transcervical injection laryngoplasty. Laryngoscope. 2017 08; 127(8):1850-1854.
-
Hyaluronic acid/carboxymethyl cellulose directly applied to transected nerve decreases axonal outgrowth. J Biomed Mater Res B Appl Biomater. 2017 04; 105(3):568-574.
-
Dexamethasone nanowafer as an effective therapy for dry eye disease. J Control Release. 2015 Sep 10; 213:168-174.
-
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Clin Cancer Res. 2015 Jan 15; 21(2):286-94.
-
Noninvasive, objective, multimodal tear dynamics evaluation of 5 over-the-counter tear drops in a randomized controlled trial. Cornea. 2012 Feb; 31(2):108-14.
-
Radiological pitfalls with laryngopharyngeal injectables. Laryngoscope. 2012 Feb; 122(2):307-10.
-
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol. 2011 Jan 20; 29(3):330-6.
-
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners. Cancer Immunol Immunother. 2010 Sep; 59(9):1401-9.
-
A highly reproducible bolus immobilization technique for the treatment of scalp malignancies. Med Dosim. 2008; 33(1):30-5.